PD1 expression was high in all of the tumor infiltrating T cells that were analyzed (>60.22 of all CD4+ or CD8+ T cells) suggesting exhaustion of these infiltrating cells and a potential role for checkpoint therapy in breast tumors with pre-existing infiltrating T cells. This evidence concerns the gene CD4 and breast neoplasm.